Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth J Pepper

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|April 15, 2014
Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitisSarah Katrina Todd, Ruth J Pepper, Juliana Draibe, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 10, 2007
Inadvertent postdialysis anticoagulation due to heparin line locksRuth J Pepper, Daniel P Gale, Julekha Wajed, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroidsMarie B Condon, Damien Ashby, Ruth J Pepper, et al.
The American Journal of Pathology|March 12, 2015
S100A8/A9 (calprotectin) is critical for development of glomerulonephritis and promotes inflammatory leukocyte-renal cell interactionsRuth J Pepper, Hsu-Han Wang, Gayathri K Rajakaruna, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2012
Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitisRuth J Pepper, Dimitrios Chanouzas, Ruth Tarzi, et al.
Rheumatology (Oxford, England)|March 11, 2014
Induction treatment of ANCA-associated vasculitis with a single dose of rituximabTabitha Turner-Stokes, Eleanor Sandhu, Ruth J Pepper, et al.
Rheumatology Advances in Practice|April 7, 2023
Cocaine-induced granulomatosis with polyangiitis-an under-recognized conditionCharn Gill, Joseph Sturman, Leyla Ozbek, et al.
The Lancet. Rheumatology|February 9, 2023
Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trialMuhammad Shipa, Liliana R Santos, Dao X Nguyen, et al.
Rheumatology (Oxford, England)|November 17, 2021
Disparity in peripheral and renal B-cell depletion with rituximab in systemic lupus erythematosus: an opportunity for obinutuzumab?Venkat R Reddy, Ruth J Pepper, Kavina Shah, et al.
Kidney International|February 21, 2013
Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritisRuth J Pepper, Sally Hamour, Konstantia-Maria Chavele, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|April 15, 2014
Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitisSarah Katrina Todd, Ruth J Pepper, Juliana Draibe, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 10, 2007
Inadvertent postdialysis anticoagulation due to heparin line locksRuth J Pepper, Daniel P Gale, Julekha Wajed, et al.
Annals of the Rheumatic Diseases|June 7, 2013
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroidsMarie B Condon, Damien Ashby, Ruth J Pepper, et al.
The American Journal of Pathology|March 12, 2015
S100A8/A9 (calprotectin) is critical for development of glomerulonephritis and promotes inflammatory leukocyte-renal cell interactionsRuth J Pepper, Hsu-Han Wang, Gayathri K Rajakaruna, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2012
Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitisRuth J Pepper, Dimitrios Chanouzas, Ruth Tarzi, et al.
Rheumatology (Oxford, England)|March 11, 2014
Induction treatment of ANCA-associated vasculitis with a single dose of rituximabTabitha Turner-Stokes, Eleanor Sandhu, Ruth J Pepper, et al.
Rheumatology Advances in Practice|April 7, 2023
Cocaine-induced granulomatosis with polyangiitis-an under-recognized conditionCharn Gill, Joseph Sturman, Leyla Ozbek, et al.
The Lancet. Rheumatology|February 9, 2023
Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trialMuhammad Shipa, Liliana R Santos, Dao X Nguyen, et al.
Rheumatology (Oxford, England)|November 17, 2021
Disparity in peripheral and renal B-cell depletion with rituximab in systemic lupus erythematosus: an opportunity for obinutuzumab?Venkat R Reddy, Ruth J Pepper, Kavina Shah, et al.
Kidney International|February 21, 2013
Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritisRuth J Pepper, Sally Hamour, Konstantia-Maria Chavele, et al.
Pageof 4